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Alterations in the composition of the gut microbiota have profound effects on human 
health. Consequently, there is great interest in identifying, characterizing, and under-
standing factors that initiate these changes. Despite their high prevalence, studies have 
only recently begun to investigate how viral lung infections have an impact on the gut 
microbiota. There is also considerable interest in whether the gut microbiota could be 
manipulated during vaccination to improve efficacy. In this highly controlled study, we 
aimed to establish the effect of viral lung infection on gut microbiota composition and 
the gut environment using mouse models of common respiratory pathogens respiratory 
syncytial virus (RSV) and influenza virus. This was then compared to the effect of live 
attenuated influenza virus (LAIV) vaccination. Both RSV and influenza virus infection 
resulted in significantly altered gut microbiota diversity, with an increase in Bacteroidetes 
and a concomitant decrease in Firmicutes phyla abundance. Although the increase in 
the Bacteroidetes phylum was consistent across several experiments, differences were 
observed at the family and operational taxonomic unit level. This suggests a change 
in gut conditions after viral lung infection that favors Bacteroidetes outgrowth but not 
individual families. No change in gut microbiota composition was observed after LAIV 
vaccination, suggesting that the driver of gut microbiota change is specific to live viral 
infection. Viral lung infections also resulted in an increase in fecal lipocalin-2, suggesting 
low-grade gut inflammation, and colonic Muc5ac levels. Owing to the important role 
that mucus plays in the gut environment, this may explain the changes in microbiota 
composition observed. This study demonstrates that the gut microbiota and the gut 
environment are altered following viral lung infections and that these changes are not 
observed during vaccination. Whether increased mucin levels and gut inflammation 
drive, or are a result of, these changes is still to be determined.
Keywords: influenza, respiratory syncytial virus infections, gut microbiota, Bacteroidetes, Firmicutes, Mucin 5ac
inTrODUcTiOn
The bacteria that colonize the gastrointestinal tract, known collectively as the gut microbiota, play 
many roles in maintaining human health, such as promoting the development of the mucosa and aid-
ing nutrient metabolism. Importantly, the microbiota protects against enteropathogen colonization 
through a range of mechanisms including the production of antimicrobial peptides, competition 
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for resources, and the induction of local immune responses 
(1). The gut microbiota also has systemic influences outside the 
gastrointestinal tract, from the wide-ranging anti-inflammatory 
effects of bacterial metabolites like short-chain fatty acids to the 
alteration of neurotransmitter production in the central nervous 
system (2, 3). One of the most studied areas is the effect of the gut 
microbiota on immune responses. Germ-free mice, which lack a 
microbiota, have reduced expression of antimicrobial peptides, 
fewer antibody-secreting cells, and deficiencies in T cell function 
(4, 5) which result in reduced responses to influenza virus infec-
tion and vaccination (6).
Given its impact on health, research has focused on under-
standing what factors influence the composition of the gut 
microbiota. Potentially, the largest contributor to gut microbiota 
composition is diet. It is thought that the distinct enterotypes 
into which most human gut microbiotas fall are shaped by diet 
(7), and everything from the amount of coffee consumed to 
bread-type preference has been linked to gut microbiota compo-
sition (8). Similarly, medication, particularly antibiotic use, can 
significantly alter gut microbiota composition, and even a short 
course of antibiotics can have long-lasting effects (9). Infection 
also shapes the gut microbiota, but the majority of research has 
focused on gastrointestinal infections or infections that have an 
impact on the immune response, such as HIV (10, 11). Despite 
their very high prevalence, little is known about how lung infec-
tions affect the gut microbiota.
Lung infections are the leading cause of death in lower-income 
countries (12) and are the single biggest cause of death in children 
under the age of 5 (13). Respiratory syncytial virus (RSV) in par-
ticular is the most common cause of bronchiolitis and pneumonia 
in infants (14), and global seasonal influenza virus epidemics are 
thought to result in three to five million severe infections every 
year (15). The importance of respiratory infections on global 
health has led many microbiota researchers to investigate how 
the gut microbiota might influence lung infection; for example, 
the depletion of the gut microbiota in mice with antibiotics has 
been associated with reduced influenza virus-specific T cell and 
antibody generation (16). Likewise, alveolar macrophages from 
germ-free mice have been shown to have reduced a phagocytic 
capacity leading to an increased susceptibility to pneumonia (17). 
As the high morbidity and mortality associated with lung infec-
tions are often due to lack of effective vaccines, there is significant 
interest in whether the gut microbiota could be manipulated to 
improve vaccine efficacy as well as response to infection (18).
Whether the “gut-lung axis” is bidirectional and lung infec-
tions influence the gut microbiota is currently under debate. 
Several studies have been published in the last few years on the 
impact of influenza virus infection on the gut microbiota, but the 
mechanisms presented behind the changes are conflicting, and 
further, more in-depth, characterization studies are required. 
In the present study, we investigated the impact of viral lung 
infection on the gut microbiota using both RSV and influenza 
virus as infection models. We also compared this to the effect 
of protective live attenuated influenza virus (LAIV) vaccination 
on the gut microbiota as many studies looking to alter the gut 
microbiota before or during vaccination do not take the effect 
that vaccination itself may have into account.
MaTerials anD MeThODs
animal experiments
Specific pathogen-free 10- to 12-week-old female BALB/c mice 
were purchased from Charles River Laboratories (Margate, 
UK). Mice were maintained in individually ventilated auto-
claved cages, with Tapvei Eco Pure Premium Aspen Chips for 
bedding (Datesand) and Sizzle Pet for nesting material (LBS), 
in groups of five animals per cage. Mice were fed irradiated SDS 
RM3 pellets (LBS) and received reverse osmosis, autoclaved 
water ad  libitum. The same specific pathogen-free room was 
used to house all mice and was maintained on a 12-h light/dark 
cycle at 20–24°C with 55 ± 10% humidity. For infection studies, 
mice were anesthetized via isoflurane inhalation and infected 
intranasally with 100 µl of 2 × 106 PFU/ml RSV-A2, 100 µl of 
4 ×  105 PFU/ml A/Eng/195/2009 influenza virus, or 100  µl 
phosphate-buffered saline (PBS). For vaccination studies, 
mice were anesthetized and infected intranasally with 1 × 106  
PFU/ml LAIV vaccine (Fluenz® Tetra, MedImmune, 2016/2017 
season), a dose shown to be protective in mice against chal-
lenge with 4 ×  105 PFU/ml A/Eng/195/2009 influenza virus. 
Mice were weighed daily after infection/vaccination, placed 
into individual disinfected pots, and feces were collected using 
autoclaved tweezers and stored in sterile tubes at −80°C. All 
animal experiments were performed in accordance with the 
United Kingdom’s Home Office guidelines under animal study 
protocol number one, and all work was approved by the Animal 
Welfare and Ethical Review board at Imperial College London. 
Studies followed the ARRIVE guidelines, and all animal 
infections and infectious work were carried out in biosafety 
level-two facilities.
rsV l gene qPcr
Viral load was assessed by extracting RNA from frozen lung and 
colon tissue disrupted in a TissueLyzer (Qiagen, Manchester, UK) 
using Trizol and converting it into cDNA using Omniscript RT 
Kit (Qiagen, Manchester, UK). RT-PCR was carried out using 
bulk viral RNA, for the RSV L gene and mRNA using the follow-
ing primers: 5'-GAACTCAGTGTAGGTAGAATGTTTGCA-3', 
5'-TTCAGCTATCATTTTCTCTGCCAA-3' and probe: 5'-FAM-
TTTGAACCTGTCTGAACAT-TAMRA-3' on a Stratagene 
Mx 3005p (Agilent technologies, Santa Clara, CA, USA). RNA 
copy number was determined using an RSV L gene standard.
16s rrna gene qPcr
Bacterial DNA was extracted from 30-mg feces/mouse using 
the FastDNA® Spin Kit for Soil (MP Biomedicals). The 16S 
rRNA gene was quantified using the SYBR Fast qPCR Kit 
Master Mix (2X, KAPA Biosystems, KK4601) and the follow-
ing primers: 5'-AYTGGGYDTAAAGNG-3', 5'-TACNVGGG 
TATCTAATCC-3' (19). Reactions were performed in triplicate 
alongside a cloned Vibrio natriegens full-length 16S rRNA gene 
standard. Reaction plates were run on the ViiA7 Real-Time 
PCR System using the following run parameters: 90°C for 3 min 
(95°C for 20 s, 50°C for 30 s, 72°C for 30 s), 40 cycles, 10 min 
at 12°C.
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16s rrna gene sequencing
The V4 variable region of the 16S rRNA gene was amplified by 
PCR using 1  µl of sample DNA, Q5® Hot Start High-Fidelity 
2X Master Mix (NEB, M0494S), and the universal bacterial 
primers S-D-Bact-0564-a-S-15: 5' AYT GGG YDT AAA GNG 
3' and S-D-Bact-0785-b-A-18: 5' TAC NVG GGT ATC TAA 
TCC 3' which were uniquely barcoded for each sample [bar-
codes: Illumina Nextera indexes version 2, primers: Klindworth 
et  al. (19)]. The 16S rRNA gene library was amplified using 
the following run parameters: 95°C for 2  min (95°C for 20  s, 
50°C for 30 s, 72°C for 5 min), 32 cycles. Each PCR was run in 
quadruplicate with a negative and positive control in each run. 
The library was purified using AMPure® XP beads (Beckman 
Coulter, A63880) and quantified using the PicoGreen® quan-
tification assay for double-stranded DNA (Thermo Fisher, 
P11496). Samples were equi-molar pooled to 45 ng/sample, and 
the pooled library was purified again and concentrated using 
AMPure® beads followed by agarose gel purification. Prior to 
sequencing, library quality was accessed by profiling using the 
High Sensitivity DNA Kit (Agilent Technologies, 5067-4626) on 
an Agilent 2100 Bioanalyzer and quantified using the illumina 
Library Quantification Kit. Paired-end sequencing of an 8-pM 
denatured library, spiked with 8 pM of PhiX, was performed 
using the Illumina MiSeq platform (20).
Bioinformatics
16S rRNA-sequencing data were processed using QIIME 
1.9.0 software suite (21). Sequences were trimmed, forward 
and reverse reads were paired, demultiplexed, and any Phix 
contamination removed using Burrows–Wheeler Aligner (22). 
Operational taxonomic units (OTUs) were clustered at 97% 
sequence identify using the UCLUST OTU-clustering tool (23) 
using open reference clustering, and representative OTUs were 
picked using the SILVA 115 rRNA database (24). Sequences were 
aligned using PyNAST (25). Chimeric sequences were identified 
and removed using ChimeraSlayer (26). Taxonomy was assigned 
using the RDP classifier (27) and the SILVA 115 rRNA database 
for reference sequences (24). An approximately maximum-
likelihood phylogenetic tree was built using FastTree 2.1.3 (28). 
Microbiota analysis was conducted in R 3.3.0 (29) with RStudio 
(30) using the phyloseq package (31) unless otherwise speci-
fied. Beta diversity was analyzed using both the phyloseq and 
the vegan package (32). Beta diversity measures the difference 
in overall bacterial community composition between different 
samples. To do this, a distance matrix using the Bray–Curtis 
dissimilarity index, which calculates differences in bacterial 
OTU abundance between samples, was created and then ana-
lyzed using non-metric multidimensional-scaling (NMDS) 
ordination. NMDS ranks the order of inter-sample distances 
which is then represented by the position of samples in the two-
dimensional ordination map; the closer together the two sample 
points are, the more similar their microbiota composition is 
(33). For each grouping variable, 95% confidence ellipses were 
calculated using the vegan package; overlapping ellipses gener-
ally indicate that microbiota composition is not significantly 
different although this was formally tested using Permutational 
Multivariate Analysis of Variance (PERMANOVA). Differences 
in OTU abundance were calculated using the DESeq2 package 
on unrarefied/untransformed data (34).
Data availability
Sequencing data will be uploaded to the European Nucleotide 
Archive under the accession number PRJEB21782. Metadata, 
mapping files, OTU tables, phylogenetic trees, and codes used 
for analysis will be uploaded to BioStudies at EMBL-EBI.
histology
Transverse 4-µm sections of colon and longitudinal 4-µm sec-
tion of lung were cut and stained with hematoxylin and eosin 
(35). Airway inflammation was assessed in a blinded manner 
using a system similar to that used by Ponnuraj et al. (36). The 
degree of colonic inflammation was assessed by counting and 
measuring the length and width of lymphoid aggregates across 
the entire section at ×20 magnification using a 10-µm eyepiece 
graticule.
cytokine elisa
Airway lavage and colon lavage fluid were collected during 
culling by flushing the airways and colon with 1,000 and 100 µl, 
respectively, of PBS. Cytokine levels in the airway and colon lav-
age were assessed using Mouse IFN-y, IL-13, or IL-17 DuoSets 
(R&D Systems, Abingdon, UK).
Mucin elisa
ELISAs to measure the level of Mucin 5 ac (Muc5ac) and Muc2 in 
the airway and colon lavage fluid were adapted from previously 
published protocols (37, 38). Briefly, plates were pre-incubated 
with carbonate buffer (pH 9.5). Airway and colonic lavage sam-
ples were then added to the carbonate buffer and incubated at 
37°C overnight. Plates were blocked with 1% BSA PBS. Mucin 
was detected with anti-Muc5ac antibody (45M1, Thermo Fisher 
Scientific, UK) or anti-Muc2 antibody (ab76774, Abcam, UK). 
For Muc5ac, goat α-mouse HRP secondary antibody was used; 
for Muc2, goat α-rabbit HRP secondary antibody was used. 
ELISAs were developed using TMB (Thermo Fisher Scientific, 
UK) and stopped using 2 N H2SO4. Plates were read at 540 nm 
using a Fluostar (Omega).
Fecal lipocalin-2
Levels of fecal lipocalin-2 are considered a more sensitive marker 
of low-grade intestinal inflammation compared to histological 
analysis (39). Lipocalin-2 levels were measured in 100-mg/ml 
feces (reconstituted in PBS 0.1% Tween 20) using Mouse Lcn-2 
DuoSet ELISA kit (R&D Systems, Abingdon, UK) as described 
previously (40).
statistics
Statistics were performed using either GraphPad Prism V6 or R 
3.3.0. Two-way repeated measures analysis of variance (ANOVA) 
with Dunnett’s correction was used to test for significant dif-
ferences in bacterial load, alpha diversity, and phyla/family 
abundance before infection/dosing and after. Significant changes 
in airway/colon inflammation and cytokine/mucin ELISAs were 
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measured using one-way ANOVA to compare infected with 
PBS controls with Dunnett’s correction. Significant changes 
in beta diversity were calculated using PERMANOVA on the 
Bray–Curtis distance matrix. Using the DESeq2 package, only 
OTUs, which significantly changed in abundance by p ≤ 0.01, 
were selected with Benjamini–Hochberg multiple-inference 
correction.
resUlTs
The composition of the gut Microbiota  
is altered following lung infection
The aim of the study was to investigate the effect of viral lung 
infection on the gut microbiota. Mice were intranasally dosed 
with RSV, PBS, or left naïve. RSV-infected animals lost weight 
on days 1, 5, 6, and 7 following infection, while PBS and naïve 
animals experienced no significant weight loss (Figure  1A). 
Viral load in the airways was highest at day 4 after infection 
and was almost undetectable by day 7 as has been shown previ-
ously (41), despite day 7 being associated with peak weight 
loss for RSV-A2 infection (42) (Figure  1B). No RSV RNA 
was detected in the colon of infected mice at either time point 
(Figure 1C). To confirm that feces were a reasonable substitute 
for sampling the colonic environment (43), we compared the 
microbiota composition of colonic and fecal samples taken 
from the same mice (Figure 1D) and found no significant dif-
ferences. Therefore, for further subsequent experiments, feces 
were used to monitor changes in the gut microbiota. Lung 
infection did not alter the total fecal bacterial load estimated 
using either 16S rRNA gene copy number (Figure 1E), total 
observed OTU (Figure 1F), or alpha diversity (Figures 1G,H). 
While the total bacterial load remained constant, the composi-
tion significantly changed on days 4 and 7 after RSV infection 
compared to day 0 (p = 0.006, Figure 1I). Composition changes 
were not observed among PBS-dosed or -naïve animals. From 
this, we conclude that RSV infection results in global changes 
to the gut microbiota.
Having seen overall diversity changes, we wished to dissect 
these changes at a phyla level. The dominant phyla in all mice, 
before and after infection, were Bacteroidetes and Firmicutes 
(~97–99% combined total relative abundance; data not 
shown). Other phyla detected were Tenericutes, Actinobacteria, 
Proteobacteria, and Deferribacteres but as these individually never 
exceeded ~2% relative abundance before or after infection, we 
decided to focus on changes in the dominant phyla. We observed 
a significant increase in the relative abundance of Bacteroidetes 
and a corresponding decrease in Firmicutes from days 0 to 7 after 
RSV infection (Figure  2A). The increase in Bacteroidetes after 
lung infection was driven by a significant increase in the rela-
tive abundance of the Bacteroidaceae family at day 7 (p ≤ 0.001; 
Figure  2B). Significant changes in individual bacterial OTUs 
belonging to the Bacteroidaceae and S24_7 families were also 
observed (Figure 2C). The decrease in Firmicutes was associated 
with a significant decrease in the relative abundance of both the 
Lachnospiraceae (p ≤ 0.05) and the Lactobacillaceae (p ≤ 0.01) 
families. While no changes were seen in naïve mice, mice dosed 
with PBS had an increase in the Firmicutes phylum and a decrease 
in Bacteroidetes, driven by an increase in the Lachnospiraceae 
family (p ≤ 0.01) (Figure 2D). Therefore, the composition of the 
gut microbiota was significantly altered following lung infection 
with a specific enrichment for Bacteroidetes.
changes in the Microbiota after lung 
infection are not influenced by cage 
effect or Passed on to Uninfected Mice
The microbiota can be affected by a wide range of environmental 
stimuli and, although housing conditions were the same for all 
groups in this study, one potential variable was that since the 
infected animals were housed separately from controls, changes 
might be driven by cage-specific effect (44). While RSV is not 
passed between mice, effects on the microbiota could be trans-
ferred by coprophagy. To test whether there were cage effects and 
whether RSV infection-associated changes in the gut microbiota 
could be passed to non-infected cage mates, RSV-infected mice 
were mixed with PBS-dosed and -naïve cage mates. Housing 
infected mice separately or together with control animals had no 
effect on weight loss; infected animals lost weight while control 
animals did not (Figures 3A,B). The beta diversity of the fecal 
microbiota significantly changed after RSV infection for mice 
either separately (p = 0.012) or co-housed (p = 0.029; Figure 3C). 
Co-housing control mice with infected mice had no effect on the 
beta diversity of the control mice. Following RSV infection, there 
was an increase in the relative abundance of Bacteroidetes and 
a corresponding decrease in Firmicutes at day 7, and this was 
unaffected by co-housing with control animals (Figure  3D). 
Therefore, cage effect did not have an impact on the microbiota 
changes seen after RSV infection.
Interestingly, while there was an increase in the relative 
abundance of families belonging to the Bacteroidetes phylum 
in both the separately and co-housed mice after RSV infection, 
this increase was driven by the significant expansion of different 
families within Bacteroidetes. RSV-infected animals in separate 
cages had a significant increase in the Porphyromonadaceae 
family (p ≤ 0.05; Figure 3E) while infected animals co-housed 
in mixed groups had an increase in the S24_7 family (p ≤ 0.05). 
The reduction in Firmicutes phylum was associated with a 
significant decrease in Lachnospiraceae and Lactobacillaceae in 
both cases.
Respiratory syncytial virus-infected mice took 28  days after 
infection to return to their original starting weight (Figure 3F). 
Changes in microbiota were transient, preceded weight recovery, 
and by day 14, there was no difference in the relative percentage 
abundance of either phylum Bacteroidetes or Firmicutes when 
compared to preinfection, demonstrating the resilience of the gut 
microbiota (Figures 3G,H).
influenza Virus infection but not 
Vaccination alters the composition  
of the gut Microbiota
To establish whether changes observed in the gut microbiota 
after lung infection were RSV-specific, mice were intranasally 
infected with H1N1 influenza A and feces collected before and 
FigUre 1 | Gut microbiota diversity is altered following viral lung infection. Adult BALB/c mice were intranasally dosed with 2 × 106 PFU/ml respiratory syncytial 
virus (RSV)-A2, sterile phosphate-buffered saline (PBS) or untreated (naïve). Feces were collected under sterile conditions before infection (D0) and at days 4 (D4) 
and 7 (D7) after infection. (a) Weight was measured after dosing. (B) Viral load in the lungs and colon (c) was estimated using RSV L gene qPCR at D4 and D7 
after infection (limit of detection LD for the assay was 2,800 copies; not detected ND 0 copies/no CT value). (D) Colonic microbiota composition (red) was compared 
to the fecal microbiota composition (black) of the same mice (shapes represent individual mice). (e) Bacterial load in the feces was estimated using 16S rRNA 
qPCR. (F) Number of operational taxonomic units (OTUs) in feces before and after infection. (g,h) Alpha diversity of the gut microbiota was analyzed using the 
phyloseq package in R v3.4.1. (i) Beta diversity of the fecal microbiota was analyzed using non-metric multidimensional scaling (NMDS) on a Brays–Curtis distance 
matrix. N = 5 mice. (e,h) Colored points represent indicial mice. Two-way repeated measures Analysis Of Variance with Dunnett’s correction was used to test for 
significant differences in viral and bacterial load. Significant changes in microbiota diversity were tested for using Permutational Multivariate Analysis of Variance. 
*p ≥ 0.05, **p ≥ 0.01, ***p ≥ 0.001.
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FigUre 2 | The ratio of Bacteroidetes to Firmicutes increases in the gut microbiota following respiratory syncytial virus (RSV) infection. (a) The relative abundance  
of the Firmicutes and Bacteroidetes phyla before and after RSV infection, phosphate-buffered saline (PBS) dosing and among naïve mice. Points represent the mean 
of N = 5 mice, ±SEM. (B) The relative abundance of each phylum splits into the most abundant gut microbiota families (only families with >1% total abundance 
included). (c) Fold change of actual operational taxonomic units (OTU) abundance after RSV infection and PBS dosing (day 7) (D) compared to before (p = 0.01 
cutoff for significance). Two-way repeated measures Analysis of Variance with Dunnett’s correction was used to test for significant differences in phyla and family 
abundance. *p ≥ 0.05, **p ≥ 0.01.
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after (D7) infection. To compare the effect of infection versus 
vaccination on the gut microbiota, a separate group of mice 
were intranasally vaccinated with a dose of LAIV known to 
confer protection against infection in mice (Figure 4A). Mice 
infected with influenza had significantly altered gut microbiota 
diversity (p = 0.008; Figure 4B), whereas there was no change in 
gut microbiota diversity after LAIV vaccination. Influenza virus 
infection also led to an increase in the ratio of Bacteroidetes to 
FigUre 3 | Respiratory syncytial virus (RSV) infection—associated changes in the gut microbiota are not due to cage effect or passed on to cage mates. BALB/c 
mice were intranasally infected with 2 × 106 PFU/ml RSV-A2, dosed with phosphate-buffered saline (PBS) or untreated, animals were either housed (a) separately 
by treatment regime or (B) co-housed with mice receiving a different treatment. (a,B) Weight was measured after treatment. (c) Feces were collected before (D0) 
and after infection (D7), and beta diversity of fecal microbiota assessed. (D) Relative abundance in microbiota at the phyla and (e) family levels. (F) BALB/c mice 
infected with RSV and housed separately were allowed to recover their lost weight. (g) Further fecal samples were taken at D14, D21, and D28, and relative 
abundance at phyla (h) and family levels assessed. N = 5, points represent the mean ± SEM. Two-way repeated measures Analysis Of Variance with Dunnett’s 
correction for multiple comparisons was used to test for significant weight loss and changes in phyla and family abundance. *p ≥ 0.05. Non-metric multidimensional 
scaling (NMDS) on a Brays–Curtis distance matrix was used to visualize diversity, and significant changes in diversity were analyzed using Permutational Multivariate 
Analysis of Variance, comparing D0–D7 for all groups and D0 between groups.
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Firmicutes (Figure 4C). This increase was driven by an increase 
in the relative abundance of the S24_7 family (p ≤ 0.01) and 
the Porphyromonadaceae family (p ≤  0.05; Figure  4D). No 
changes in phyla or family abundance among vaccinated or 
control animals were observed (Figures  4C,D). Therefore, 
following both RSV and influenza virus infection, there is an 
increase in the abundance of the Bacteroidetes phylum while 
LAIV vaccination does not have a significant impact on the 
gut microbiota.
lung infection is associated with an 
increase in low-grade gut inflammation 
and colonic Muc5ac levels
Previous studies investigating the connection between the gut 
microbiota and lung infections have focused on the exploration 
of potential immunological mechanisms (16, 17, 45). In the 
present study, significant upper airway inflammation after RSV 
infection and significant upper and lower airway inflammation 
after influenza virus infection were observed (Figure  5A). 
FigUre 4 | The gut microbiota is altered following influenza virus infection, but not live attenuated influenza virus (LAIV) vaccine. BALB/c mice were intranasally 
infected with 4 × 105 PFU/ml A/Eng/195/09 influenza virus, intranasally immunized with 1 × 106 PFU/ml LAIV or intranasally dosed with phosphate-buffered saline 
(PBS). Vaccinated mice were challenged with 4 × 105 PFU/ml A/Eng/195/09 influenza virus 3 weeks later to establish that this dose of LAIV was protective against 
infection. Feces were collected before (D0) and after primary infection/immunization (D7). (a) Weight loss was recorded for 7 days after primary infection/
immunization and for an additional 7 days after immunized mice were challenged. (B) Beta diversity of the fecal microbiota before and after influenza virus infection, 
LAIV immunization, and PBS dosing. (c) The relative abundance of the Firmicutes and Bacteroidetes phyla. (D) The relative abundance of Bacteroidetes and 
Firmicutes splits into the most abundant families (>1% total abundance) before and after influenza virus infection, LAIV immunization, and PBS dosing. N = 5, points 
represent the mean ± SEM. Two-way repeated measures analysis of variance with Dunnett’s correction for multiple comparisons was used to test for significant 
weight loss and changes in phyla and family abundance. *p ≥ 0.05, **p ≥ 0.01, ***p ≥ 0.001. Non-metric multidimensional-scaling (NMDS) on a Brays–Curtis 
distance matrix was used to visualize diversity, and significant changes in diversity were analyzed using Permutational Multivariate Analysis of Variance comparing 
D0–D7.
8
Groves et al. Lung Infection Alters Gut Microbiota
Frontiers in Immunology | www.frontiersin.org February 2018 | Volume 9 | Article 182
However, there was no evidence of any significant histological 
colonic inflammation after either RSV or influenza infection 
(Figures  5B,C). Fecal levels of lipocalin-2 are considered a 
more sensitive marker of gut inflammation that histological 
analysis (39); we observed significantly higher fecal lipocalin-2 
levels after RSV infection, suggesting that viral lung infections 
may result in low-grade gut inflammation (Figure  5D). To 
explore this further, levels of cytokines in airway and colonic 
lavage were measured after RSV infection. IFN-γ was elevated 
after RSV infection in the airways but not in the colonic lav-
age, and no significant increases in levels of IL-13 or IL-17 at 
either site were found (Figure 5E). RSV and influenza viruses, 
similar to most respiratory pathogens, cause elevated mucus 
secretion in the airways. As mucus is nutrient rich, raising 
its level in the guts either by swallowing airway mucus or by 
systemic hypersecretion could explain the bloom in certain 
FigUre 5 | Respiratory infection results in increased colonic Mucin 5ac (Muc5ac) and low-grade gut inflammation. (a) Peribronchiolar, perivascular, and interstitial 
airway inflammation was assessed in a blinded manner for the upper and lower airways and combined together to give a combined inflammatory score. (B,c) 
Colonic inflammation was scored by counting and measuring the number (B) and size (c) of lymphoid aggregates in the colonic epithelium. (D) Low-grade gut 
inflammation was assessed by measuring fecal lipocalin-2 levels. (e) IL-17, IL-13, and IFN-y cytokine levels were measured in the bronchoalveolar lavage fluid 
(airways) and colonic lavage fluid (colon) after respiratory syncytial virus (RSV) infection or phosphate-buffered saline (PBS) dosing. (F) Muc5ac levels were measured 
in the airway and colon after RSV infection, H1N1 infection, and PBS dosing. N = 5–10 mice/group ± SEM, two-way analysis of variance. *p ≥ 0.05, **p ≥ 0.01, 
***p ≥ 0.001.
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microbiota members. Many members of the gut microbiota, 
including members of the Bacteroidetes phylum, use mucus 
as an energy source (46). Interestingly, Muc5ac levels were 
significantly increased in both the airways and the colon of 
RSV or influenza virus-infected mice but not in those of control 
mice (Figure 5F). These findings suggest that the changes in gut 
microbiota composition observed after both lung infections 
could be due to the mucus hypersecretion induced by both 
respiratory viruses.
DiscUssiOn
In the current study, we demonstrate that the composition of the 
gut microbiota changes after viral lung infection. This study also 
contributes to understanding the complex relationship between 
the gut microbiota and influenza infection and, for the first time, 
characterizes how the gut microbiota is altered following RSV 
infection. Viral lung infection led to an increase in the phylum 
Bacteroidetes with a corresponding decrease in the Firmicutes 
phylum. The constituent bacteria that drove these changes varied 
at the family and OTU levels, suggesting that viral lung infection 
creates conditions favorable to support a Bacteroidetes bloom, 
but that the species that make up this bloom are selected by cur-
rently unknown factors. In addition, we observed no change in 
gut microbiota diversity or composition after LAIV vaccination, 
emphasizing that the observed changes are dependent upon 
infection and providing a preliminary baseline for future studies 
investigating the impact of vaccination on the gut microbiota and 
vice versa.
As in humans, the majority of the murine gut and fecal 
microbiota belongs to either the Firmicutes or Bacteroidetes phyla 
(47, 48), and a change in the balance between the two has been 
previously implicated in many diseases and disorders (49). We 
observed an increase in Bacteroidetes and a decrease in Firmicutes 
in the gut microbiota of mice following lung infection. A decrease 
in the relative abundance of Firmicutes has been reported in a 
chronic mild stress model in mice, with a specific reduction of 
gut Lactobacillus (50), suggesting that changes in gut microbiota 
composition observed by us and others may be more reflective of 
a stress response. A decrease in Lactobacillus, detected by PCR, 
has previously been observed after influenza infection (51), and in 
this study, we consistently saw a decrease in the Lactobacillaceae 
family after viral lung infection. Other studies investigating the 
effect of influenza virus in mice have highlighted an increase in 
the Proteobacteria phylum after infection (52, 53). In our study, 
the relative abundance of Proteobacteria never exceeded ~0.01%, 
and there was no change after infection. Although no significant 
increase in the relative abundance of the Bacteroidetes phylum 
was observed in these previous studies, the abundance of OTUs 
belonging to Bacteroidetes correlated most significantly with 
weight loss after influenza infection (52). No comparative study 
in humans investigating the direct effect of lung infections on the 
gut microbiota has currently been published. However, one group, 
which profiled the gut microbiota of infants with and without 
10
Groves et al. Lung Infection Alters Gut Microbiota
Frontiers in Immunology | www.frontiersin.org February 2018 | Volume 9 | Article 182
bronchiolitis, found that there was a strong positive association 
between a high Bacteroidetes abundance in the gut microbiota 
and bronchiolitis, and, interestingly, 65% of these bronchiolitis 
cases were RSV-positive (54).
The changes that have been observed in the gut microbiota 
occurring after lung infection remain unclear. Studies in mice 
have suggested that the immune response to influenza virus 
infection in the lungs shapes gut microbiota composition, 
with both type I (53) and type II interferons (51) proposed 
to have a role. Our observation that different families within 
the Bacteroidetes phylum increase in abundance suggests 
that rather than the specific targeting of certain microbiota 
members by the immune system, respiratory infection causes 
a change in the gut environment, favoring the expansion of 
Bacteroidetes, and whichever Bacteroidetes family gains the 
advantage first increases in abundance. We speculate that one 
factor contributing to these changes is mucus. We observed 
increased levels of mucin Muc5ac in the colon, where it is not 
normally expressed (55, 56). This increase may be due to mice 
swallowing the excess mucus produced in the airways after 
infection or it may be that Muc5ac expression in colonic goblet 
cells is stimulated by the viral infection. The main role of mucus 
is defense against microbial exposure, but mucus is also utilized 
by these same microbes to gain an advantage in the extremely 
competitive microbiota environment (57). Bacteria, which 
can use mucins as an energy source, may have an ecological 
advantage if mucus composition changes. This has been seen 
elsewhere; changes in vaginal microbiota composition were 
associated with increased cervical Muc5B and Muc5ac levels 
(58) but the impact of respiratory mucus on the gut microbiota 
has not been previously studied.
An alternative explanation for the changes in microbiota 
composition observed after lung infection is infection-induced 
weight loss. Diet is the biggest contributor to microbiota com-
position (59), and reduced calorific intake in humans has been 
associated with a significant increase in Bacteroidetes abun-
dance over Firmicutes (60, 61), similar to what was observed 
in this study after both RSV and influenza virus infection. In 
addition, calorie reduction in conjunction with influenza infec-
tion has been shown to enhance the gut microbiota changes 
observed after influenza infection alone (52). Bacteroidetes are 
considered very metabolically flexible (62), and mouse models 
of nutrient deprivation have been shown to switch their gene 
expression profile from enzymes capable of metabolizing 
dietary polysaccharides to enzymes which break down host 
mucus glycans (63). Therefore, it may be that the increase in 
Bacteroidetes observed after lung viral infection is due to a 
reduced food intake, and the increase in mucus observed in the 
gut may be compensatory for increased mucus metabolism by 
the gut bacteria.
One interesting feature of this study was the increase in S24_7 
abundance observed after lung infection. Despite being a very 
common constituent of the murine gut microbiota, only one 
member of this strictly anaerobic family has been isolated and 
cultured: Muribaculum intestinale (64). There is some contro-
versy about whether S24_7 is mouse-specific (65) or part of the 
gut microbiota in humans (66). Equally, the impact of S24_7 on 
health is unclear; while some studies have associated increased 
S24_7 levels with inflammation, there are conflicting theories 
on whether S24_7 is the cause of (67) or the response to (40) 
the inflammation. Supporting our hypothesis that changes in gut 
microbiota after lung infection are driven by elevated mucus, the 
increased abundance of both S24_7 and the mucin-degrading 
bacteria Akkermansia muciniphilia has been observed in a gut 
infection/inflammation model (40), suggesting that S24_7 has a 
mucin-degrading ability. Likewise, the genetic analysis of S24_7 
has revealed that some members of S24_7 have a tropism for host 
glycans (such as mucin) (66). In future studies, it will be interest-
ing to determine the role of this family.
While the changes observed in the present study are robust 
and reproducible, the functional implications of the shift in 
microbiota after viral lung infection remain unclear. Changes in 
the gut microbiota have been associated with, and may in some 
circumstance amplify, disease. The decrease in Lactobacillus 
seen in the chronic stress model in mice (50) was associated 
with increased kynurenine, which is associated with depression. 
Changes in microbiota may also drive the gastrointestinal symp-
toms associated with influenza infection (68). We did observe an 
increase in lipocalin-2 in the feces which is associated with gut 
inflammation. These could be attributed to viral infection of the 
gastrointestinal tract, but in our study, and in others, no viral 
RNA was detected in the colonic tissue (51). If changes in micro-
biota were found in future studies to be associated with increased 
disease, therapeutic restoration of the preinfection balance may 
reduce disease. The majority of studies in humans and mice look-
ing to improve the immune response and ameliorate disease in 
influenza virus infection have used various Lactobacillus spp. as 
probiotics with some success (18). Enriching the gut microbiota 
for Lactobacillus has also been shown to protect against airway 
inflammation in RSV infection (69). Overall, demonstrating that 
viral lung infection changes the gut microbiome is an important 
first step to investigating how these changes might have an impact 
on both respiratory and gut health, both in an infection setting 
and during vaccination.
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